Rocket


Overview
Financials
News + Filings

 
 

Stoke Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues8.43.6
            Revenue growth132.7% 
Cost of goods sold12.85.6
Gross profit-4.4-2.0
            Gross margin-52.7%-54.4%
General and administrative4.42.0
EBIT-12.8-5.6
            EBIT margin-152.7%-154.4%
Pre-tax income-12.5-5.6
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-12.5-5.6
            Net margin-149.6%-154.5%
 
Diluted EPS($17.65)($8.29)
Shares outstanding (diluted)0.70.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy